Integrated PharmaQuest Technologies, Inc.

Integrated PharmaQuest Technologies, Inc. (IPT) is an early stage drug discovery company engaged in the discovery of orally active drugs, using its proprietary Combinatorial Chemistry Technologies (TLD, HSCS and RPPLi ) integrated with Rational Design, at a highly accelerated pace to reduce time and cost of R&D to develop small molecule drugs. IPT establishes drug discovery and lead optimization collaborations with pharmaceutical and biotech companies to accelerate discovery of drug candidates as well as provides diverse libraries of novel compounds for biological screening to pharmaceutical and biotech industry. IPT also provides custom designed libraries and new synthetic chemistry for the high speed synthesis of small molecule libraries for the fast-pace discovery of therapeutics. IPT's platform drug discovery technology is applicable to identify and optimize new lead compounds to drug candidates in a wide range of diseases including cancer, central nervous system disorders, cardiovascular disorders, diabetes, obesity, aging, inflammation, viral and autoimmune diseases.

Activity:

- Research & Development

Product / Technology type(s) covered:

- Bio
- NCE (new chemical entities)
- Technology

Therapeutic targets:

- Aging
- Cancer
- Cardiovascular
- Central nervous system
- Diabetes
- Infectious Diseases

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: